Akoya Biosciences, Inc. Quarterly Operating Margin in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Akoya Biosciences, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q3 2024.
  • Akoya Biosciences, Inc. Operating Margin for the quarter ending September 30, 2024 was -58.1 %, a 19.3% increase year-over-year.
  • Akoya Biosciences, Inc. annual Operating Margin for 2023 was -59.7 %, a 32.4% increase from 2022.
  • Akoya Biosciences, Inc. annual Operating Margin for 2022 was -88.3 %, a 23.4% decline from 2021.
  • Akoya Biosciences, Inc. annual Operating Margin for 2021 was -71.6 %, a 153% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -58.1 +13.9 +19.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -57.6 +25.9 +31% Apr 1, 2024 Jun 30, 2024
Q1 2024 -66.1 +19.6 +22.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -59.7 +28.6 +32.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -72 +21.5 +23% Jul 1, 2023 Sep 30, 2023
Q2 2023 -83.4 +8.74 +9.48% Apr 1, 2023 Jun 30, 2023
Q1 2023 -85.7 -2.68 -3.23% Jan 1, 2023 Mar 31, 2023
Q4 2022 -88.3 -16.8 -23.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -93.6 -43.9 -88.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -92.2 -53.6 -139% Apr 1, 2022 Jun 30, 2022
Q1 2022 -83 -46.2 -126% Jan 1, 2022 Mar 31, 2022
Q4 2021 -71.6 -43.3 -153% Oct 1, 2021 Dec 31, 2021
Q3 2021 -49.7 Jul 1, 2021 Sep 30, 2021
Q2 2021 -38.6 Apr 1, 2021 Jun 30, 2021
Q1 2021 -36.8 Jan 1, 2021 Mar 31, 2021
Q4 2020 -28.3 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.